Cognitive behavioural therapy with behavioural analysis for pharmacological treatment-resistant chronic insomnia

Psychiatry Research

Volumn 210, Issue 2, 2013, Pages 515-521

  Okajima, Isa ^a,b,c   Nakamura, Masaki ^a,b,c   Nishida, Shingo ^a,b,c   Usui, Akira ^a,b,c   Hayashida, Ken ichi ^a,d   Kanno, Meri ^a,d   Nakajima, Shun ^a,b,c   Inoue, Yuichi ^a,b,c  

^a NEUROPSYCHIATRIC RESEARCH INSTITUTE   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

^c Yoyogi Sleep Disorder Center   (Japan)

^d Sleep and Stress Clinic   (Japan)

Author keywords

Behavioural analysis; Cognitive behavioural therapy; Hypnotics; Insomnia; Treatment resistant

Indexed keywords

BROTIZOLAM; ESTAZOLAM; FLUDIAZEPAM; FLUNITRAZEPAM; HYPNOTIC AGENT; LORMETAZEPAM; NITRAZEPAM; QUAZEPAM; TRIAZOLAM; ZOLPIDEM; ZOPICLONE; HYPNOTIC SEDATIVE AGENT;

ADULT; AGED; ARTICLE; BEHAVIORAL RESEARCH; CHRONIC DISEASE; COGNITIVE THERAPY; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG DOSE REDUCTION; DRUG EFFICACY; FEMALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MUSCLE RELAXATION; OPEN STUDY; OUTCOME ASSESSMENT; POST HOC ANALYSIS; PRIORITY JOURNAL; QUASI EXPERIMENTAL STUDY; SLEEP DEPRIVATION; SLEEP TIME; SYMPTOM; THERAPY EFFECT; TREATMENT DURATION; COGNITION; DEPRESSIVE DISORDER; GROUP THERAPY; INTERVENTION STUDY; MIDDLE AGED; PROCEDURES; PSYCHOLOGICAL RATING SCALE; QUESTIONNAIRE; SEVERITY OF ILLNESS INDEX; SLEEP INITIATION AND MAINTENANCE DISORDERS; SOCIOECONOMICS; TREATMENT OUTCOME;

ADULT; AGED; COGNITION; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; DEPRESSIVE DISORDER; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; INTERVENTION STUDIES; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY, GROUP; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SLEEP INITIATION AND MAINTENANCE DISORDERS; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME;

EID: 84886953239     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2013.06.028     Document Type: Article

References (55)

1. The international classification of sleep disorders: Diagnostic and coding manual 2005, American Academy of Sleep Medicine, American Academy of Sleep Medicine, Westchester, IL. 2nd ed.
2. Diagnostic criteria from DSM-IV-TR 2000, American Psychiatric Association, American Psychiatric Association, Washington, DC.
3. Ancoli-Israel S., Roth T. Characteristics of insomnia in the United States: Results of the 1991 National Sleep Foundation Survey. I. Sleep 1999, 22(Suppl 2):S347-353.
4. Barrett J., Hurst M.W., Discala C., Rose R.M. Prevalence of depression over a 12-month period in a nonpatient population. Archives of General Psychiatry 1978, 35:741-744.
5. Belleville G., Guay C., Guay B., Morin C.M. Hypnotic taper with or without self-help treatment of insomnia: a randomized clinical trial. Journal of Consulting and Clinical Psychology 2007, 75:325-335.
6. Buysse D.J., Angst J., Gamma A., Ajdacic V., Eich D., Rossler W. Prevalence, course, and comorbidity of insomnia and depression in young adults. Sleep 2008, 31:473-480.
7. Buysse D.J., Reynolds C.F., Monk T.H., Berman S.R., Kupfer D.J. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Research 1989, 28:193-213.
8. Cohen J. Statistical power analysis for the behavioral sciences 1988, Erlbaum Associates, Hillsdale, NJ. 2nd ed.
9. Davidson J.R., Aime A., Ivers H., Morin C.M. Characteristics of individuals with insomnia who seek treatment in a clinical setting versus those who volunteer for a randomized controlled trial. Behavioral Sleep Medicine 2009, 7:37-52.
10. Dimidjian S., Hollon S.D., Dobson K.S., Schmaling K.B., Kohlenberg R.J., Addis M.E., Gallop R., McGlinchey J.B., Markley D.K., Gollan J.K., Atkins D.C., Dunner D.L., Jacobson N.S. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. Journal of Consulting and Clinical Psychology 2006, 74:658-670.
11. Doi Y., Minowa M., Uchiyama M., Okawa M., Kim K., Shibui K., Kamei Y. Psychometric assessment of subjective sleep quality using the Japanese version of the Pittsburgh Sleep Quality Index (PSQI-J) in psychiatric disordered and control subjects. Psychiatry Research 2000, 97:165-172.
12. Edinger J.D., Carney C. Overcoming insomnia: a cognitive-behavioral therapy approach: Therapist guide 2008, Oxford University Press, New York.
13. Fava M., McCall W.V., Krystal A., Wessel T., Rubens R., Caron J., Amato D., Roth T. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biological Psychiatry 2006, 59:1052-1060.
14. Ford D.E., Kamerow D.B. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention?. Journal of the American Medical Association 1989, 262:1479-1484.
15. Galizio M. Contingency-shaped and rule-governed behavior: Instructional control of human loss avoidance. Journal of the Experimental Analysis of Behavior 1979, 31:53-70.
16. Ghaderi A. Does individualization matter? A randomized trial of standardized (focused) versus individualized (broad) cognitive behavior therapy for bulimia nervosa. Behaviour Research and Therapy 2006, 44:273-288.
17. Griffiths R.R., Johnson M.W. Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds. Journal of Clinical Psychiatry 2005, 66(Suppl 9):31-41.
18. Hayes S.C. Rule-governed behavior: cognition, contingencies, and instructional control 1989, Plenum Press, New York.
19. Hayes S.C., Strosahl K., Wilson K.G. Acceptance and commitment therapy: an experiential approach to behavior change 1999, Guilford Press, New York.
20. Hindmarch I. Residual effects of hypnotics: An update. Journal of Clinical Psychiatry 1991, 52:14-15.
21. Kanter J.W., Manos R.C., Busch A.M., Rusch L.C. Making behavioral activation more behavioral. Behavior Modification 2008, 32:780-803.
22. Kazdin A.E. Research design in clinical psychology 2003, Allyn and Bacon, Boston. 4th ed.
23. Kim K., Uchiyama M., Okawa M., Liu X., Ogihara R. An epidemiological study of insomnia among the Japanese general population. Sleep 2000, 23:41-47.
24. Komada Y., Nomura T., Kusumi M., Nakashima K., Okajima I., Sasai T., Inoue Y. Correlations among insomnia symptoms, sleep medication use and depressive symptoms. Psychiatry and Clinical Neurosciences 2011, 65:20-29.
25. Lichstein K.L., Durrence H.H., Taylor D.J., Bush A.J., Riedel B.W. Quantitative criteria for insomnia. Behaviour Research and Therapy 2003, 41:427-445.
26. Lowe C.F. Determinants of human behavior. Reinforcement and the organization of behavior 1979, Vol. 1. Wiley and Sons, New York.
27. Manber R., Edinger J.D., Gress J.L., San Pedro-Salcedo M.G., Kuo T.F., Kalista T. Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia. Sleep 2008, 31:489-495.
28. Martell C.R., Addis M.E., Jacobson N.S Depression in context: strategies for guided action 2001, W.W. Norton & Company, New York.
29. Martin J.L., Ancoli-Israel S. Assessment and diagnosis of insomnia in non-pharmacological intervention studies. Sleep Medicine Reviews 2002, 6:379-406.
30. McQuay H.J., Moore R.A. Using numerical results from systematic reviews in clinical practice. Annals of Internal Medicine 1997, 126:712-720.
31. Mellinger G.D., Balter M.B., Uhlenhuth E.H. Insomnia and its treatment. Prevalence and correlates. Archives of General Psychiatry 1985, 42:225-232.
32. Mimeault V., Morin C.M. Self-help treatment for insomnia: Bibliotherapy with and without professional guidance. Journal of Consulting and Clinical Psychology 1999, 67:511-519.
33. Morgan K., Dixon S., Mathers N., Thompson J., Tomeny M. Psychological treatment for insomnia in the management of long-term hypnotic drug use: a pragmatic randomised controlled trial. British Journal of General Practice 2003, 53:923-928.
34. Morin C.M., Bastien C., Guay B., Radouco-Thomas M., Leblanc J., Vallieres A. Randomized clinical trial of supervised tapering and cognitive behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia. American Journal of Psychiatry 2004, 161:332-342.
35. Morin C.M., Colecchi C., Stone J., Sood R., Brink D. Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. Journal of American Medical Association 1999, 281:991-999.
36. Morin C.M., Espie C.A. Insomnia: a clinical guide to assessment and treatment 2004, Springer, New York.
37. Morin C.M., Hauri P.J., Espie C.A., Spielman A.J., Buysse D.J., Bootzin R.R. Nonpharmacologic treatment of chronic insomnia. An American Academy of Sleep Medicine review. Sleep 1999, 22:1134-1156.
38. Morin C.M., Vallieres A., Guay B., Ivers H., Savard J., Merette C., Bastien C., Baillargeon L. Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial. Journal of the American Medical Association 2009, 301:2005-2015.
39. Ohayon M.M. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Medicine Reviews 2002, 6:97-111.
40. Okajima I., Komada Y., Inoue Y. A meta-analysis on the treatment effectiveness of cognitive behavioral therapy for primary insomnia. Sleep and Biological Rhythms 2011, 9:24-34.
41. Okajima I., Komada Y., Nomura T., Nakashima K., Inoue Y. Insomnia as a risk for depression: a longitudinal epidemiological study on a Japanese rural cohort. Journal of Clinical Psychiatry 2012, 73:377-383.
42. Okajima, I., Nakajima, S., Kobayashi, M., & Inoue, Y., In press. Development and validation of the Japanese version of the Athens Insomnia Scale (AIS-J). Psychiatry and Clinical Neurosciences.
43. Ramnero J., Törneke N. The ABCs of human behavior: Behavioral principles for the practicing clinician 2008, New Harbinger, Oakland.
44. Sasai T., Inoue Y., Komada Y., Nomura T., Matsuura M., Matsushima E. Effects of insomnia and sleep medication on health-related quality of life. Sleep Medicine 2010, 11:452-457.
45. Smith M.T., Perlis M.L., Park A., Smith M.S., Pennington J., Giles D.E., Buysse D.J. Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. American Journal of Psychiatry 2002, 159:5-11.
46. Soeffing J.P., Lichstein K.L., Nau S.D., McCrae C.S., Wilson N.M., Aguillard R.N., Lester K.W., Bush A.J. Psychological treatment of insomnia in hypnotic-dependant older adults. Sleep Medicine 2008, 9:165-171.
47. Soldatos C.R., Dikeos D.G., Paparrigopoulos T.J. Athens Insomnia Scale: Validation of an instrument based on ICD-10 criteria. Journal of Psychosomatic Research 2000, 48:555-560.
48. Soldatos C.R., Dikeos D.G., Paparrigopoulos T.J. The diagnostic validity of the Athens Insomnia Scale. Journal of Psychosomatic Research 2003, 55:263-267.
49. Soldatos C.R., Dikeos D.G., Whitehead A. Tolerance and rebound insomnia with rapidly eliminated hypnotics: a meta-analysis of sleep laboratory studies. International Clinical Psychopharmacology 1999, 14:287-303.
50. Stepanski E., Koshorek G., Zorick F., Glinn M., Roehrs T., Roth T. Characteristics of individuals who do or do not seek treatment for chronic insomnia. Psychosomatics 1989, 30:421-427.
51. US Food and Drug Administration. FDA drug safety communication: Risk of next-morning impairment after use of insomnia drugs; FDA requires lower recommended doses for certain drugs containing zolpidem (Ambien, Ambien CR, Edluar, and Zolpimist). Accessed March 2013. http://www.fda.gov/downloads/Drugs/DrugSafety/UCM335007.pdf.
52. Watanabe N., Furukawa T.A., Shimodera S., Morokuma I., Katsuki F., Fujita H., Sasaki M., Kawamura C., Perlis M.L. Brief behavioral therapy for refractory insomnia in residual depression: an assessor-blind, randomized controlled trial. Journal of Clinical Psychiatry 2011, 72:1651-1658.
53. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines 1992, World Health Organization, World Health Organization, Geneva.
54. Zavesicka L., Brunovsky M., Matousek M., Sos P. Discontinuation of hypnotics during cognitive behavioural therapy for insomnia. BioMed Central Psychiatry 2008, 8:80.
55. Zung W.W. A self-rating depression scale. Archives of General Psychiatry 1965, 12:63-70.